These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 12395898

  • 1. Ductal and acinar differentiation in pancreatic endocrine tumors.
    Kamisawa T, Tu Y, Egawa N, Ishiwata J, Tsuruta K, Okamoto A, Hayashi Y, Koike M, Yamaguchi T.
    Dig Dis Sci; 2002 Oct; 47(10):2254-61. PubMed ID: 12395898
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
    Grippo PJ, Sandgren EP.
    Int J Cancer; 2012 Sep 01; 131(5):1243-8. PubMed ID: 22024988
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic acinar cell carcinoma with endocrine differentiation: immunohistochemical and ultrastructural analyses.
    Tobita K, Kijima H, Chino O, Dowaki S, Kashiwagi H, Tanaka M, Ohtani Y, Inokuchi S, Makuuchi H.
    Anticancer Res; 2001 Sep 01; 21(3C):2131-4. PubMed ID: 11501836
    [Abstract] [Full Text] [Related]

  • 6. Mixed acinar-endocrine carcinomas of the pancreas.
    Klimstra DS, Rosai J, Heffess CS.
    Am J Surg Pathol; 1994 Aug 01; 18(8):765-78. PubMed ID: 8037290
    [Abstract] [Full Text] [Related]

  • 7. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS, Orlandini S, Zamboni G, Capelli P, Rigaud G, Falconi M, Bassi C, Lemoine NR, Scarpa A.
    Br J Cancer; 2001 Jan 01; 84(2):253-62. PubMed ID: 11161385
    [Abstract] [Full Text] [Related]

  • 8. Where and when does pancreatic carcinoma start?
    Lüttges J, Hahn S, Klöppel G.
    Med Klin (Munich); 2004 Apr 15; 99(4):191-5. PubMed ID: 15085289
    [Abstract] [Full Text] [Related]

  • 9. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.
    Hoorens A, Lemoine NR, McLellan E, Morohoshi T, Kamisawa T, Heitz PU, Stamm B, Rüschoff J, Wiedenmann B, Klöppel G.
    Am J Pathol; 1993 Sep 15; 143(3):685-98. PubMed ID: 8362971
    [Abstract] [Full Text] [Related]

  • 10. Mixed ductal-endocrine carcinoma of the pancreas presenting as gastrinoma with Zollinger-Ellison syndrome: an autopsy case with a 24-year survival period.
    Terada T, Matsunaga Y, Maeta H, Endo K, Horie S, Ohta T.
    Virchows Arch; 1999 Dec 15; 435(6):606-11. PubMed ID: 10628803
    [Abstract] [Full Text] [Related]

  • 11. Novel Insights Into Immunohistochemical Analysis For Acinar Cell Neoplasm of The Pancreas: Carboxypeptidase A2, Carboxypeptidase A1, and Glycoprotein 2.
    Ishimoto-Namiki U, Ino Y, Esaki M, Shimada K, Saruta M, Hiraoka N.
    Am J Surg Pathol; 2023 May 01; 47(5):525-534. PubMed ID: 36815573
    [Abstract] [Full Text] [Related]

  • 12. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC, Klimstra DS, Varmus HE.
    Genes Dev; 2003 Dec 15; 17(24):3127-38. PubMed ID: 14681205
    [Abstract] [Full Text] [Related]

  • 13. [The establishment of a human pancreatic mixed ductal-endocrine carcinoma cell line].
    Hou M, Gao J, Liu T, Cui Q.
    Zhonghua Bing Li Xue Za Zhi; 1999 Dec 15; 28(6):422-6. PubMed ID: 11869555
    [Abstract] [Full Text] [Related]

  • 14. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV, Basturk O, Cheng JD, Andea AA.
    Semin Radiat Oncol; 2005 Oct 15; 15(4):254-64. PubMed ID: 16183479
    [Abstract] [Full Text] [Related]

  • 15. Total pancreatectomy for metachronous mixed acinar-ductal carcinoma in a remnant pancreas.
    Shonaka T, Inagaki M, Akabane H, Yanagida N, Shomura H, Yanagawa N, Oikawa K, Nakano S.
    World J Gastroenterol; 2014 Sep 07; 20(33):11904-9. PubMed ID: 25206298
    [Abstract] [Full Text] [Related]

  • 16. [PET and PET-CT of malignant tumors of the exocrine pancreas].
    Reske SN.
    Radiologe; 2009 Feb 07; 49(2):131-6. PubMed ID: 19219476
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.
    Hosoda W, Takagi T, Mizuno N, Shimizu Y, Sano T, Yamao K, Yatabe Y.
    Pathol Int; 2010 May 07; 60(5):358-64. PubMed ID: 20518885
    [Abstract] [Full Text] [Related]

  • 18. Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.
    Aguilar S, Corominas JM, Malats N, Pereira JA, Dufresne M, Real FX, Navarro P.
    Am J Pathol; 2004 Oct 07; 165(4):1129-39. PubMed ID: 15466380
    [Abstract] [Full Text] [Related]

  • 19. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
    Basturk O, Zamboni G, Klimstra DS, Capelli P, Andea A, Kamel NS, Adsay NV.
    Am J Surg Pathol; 2007 Mar 07; 31(3):363-70. PubMed ID: 17325477
    [Abstract] [Full Text] [Related]

  • 20. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.
    Fujita Y, Uesugi N, Sugimoto R, Eizuka M, Matsumoto T, Sugai T.
    Diagn Pathol; 2019 May 10; 14(1):38. PubMed ID: 31077220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.